Gene · 9356
Papers1,877
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,877
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Microfluidic innovations in chronic kidney disease and renal fibrosis: from mechanistic insights to clinical applications. | Front Med (Lausanne) | 2026 | 41743084 | PubTator, text mining | PubMed |
| Injury-Induced Epithelial Spp1 Engages Cd44 to Promote Neutrophil Recruitment and Exacerbate Acute Kidney Injury. | J Inflamm Res | 2026 | 41737246 | PubTator, text mining | PubMed |
| Lack of Modulation of In Vivo Activity of Organic Anion Transporters 1 and 3 in Pregnancy Using Furosemide as a Probe. | J Clin Pharmacol | 2026 | 41729123 | PubTator, text mining | PubMed |
| The Role of Metabolites in Acyclovir-Induced Neurotoxicity and Nephrotoxicity. | Medicines (Basel) | 2026 | 41718166 | PubTator, text mining | PubMed |
| The kidney in genetic metabolic disorders. | Med Genet | 2026 | 41710423 | PubTator, text mining | PubMed |
| Dicloxacillin and Flucloxacillin Inhibit Hepatic Uptake Transporters-In Vitro Investigations and Physiologically Based Pharmacokinetic Modeling. | Clin Transl Sci | 2026 | 41630535 | PubTator, text mining | PubMed |
| Expression of drug transporters in human allogenic transplanted kidneys in acute rejection. | Toxicol Appl Pharmacol | 2026 | 41581572 | PubTator, text mining | PubMed |
Understanding Pharmacokinetic-Drug Interactions With Drugs Approved by the US Food and Drug Administration in 2024 to Better Manage the Risk of Drug Interactions With Concomitant Medications: A Review of Clinical Data From New Drug Applications. | Curr Ther Res Clin Exp | 2026 | 41567854 | PubTator, text mining | PubMed |
| Three-dimensional-cultured renal tubular model reveals FXR-HNF4α-OAT1/3 axis as a target for preventing nucleotide analog-induced kidney injury. | Drug Metab Dispos | 2026 | 41447817 | PubTator, text mining | PubMed |
| Inhibition of human organic anion transporter 4 (OAT4) activity by bisphenol analogues. | Environ Pollut | 2026 | 41407188 | PubTator, text mining | PubMed |
| A Rational Approach to Pharmacotherapy in Pregnancy. | J Clin Pharmacol | 2026 | 41405555 | PubTator, text mining | PubMed |
| Organic anion transporter 1 (OAT1) is a mechanism for uptake of mercuric-cyanide complexes into proximal tubular cells. | Environ Toxicol Pharmacol | 2026 | 41391530 | PubTator, text mining | PubMed |
| An in vitro-in silico workflow for predicting renal clearance of environmental chemicals and drugs. | Toxicology | 2026 | 41224188 | PubTator, text mining | PubMed |
| Mechanism of Sodium-Glucose Cotransporter-2 Inhibitors for Uricosuria. | Electrolyte Blood Press | 2025 | 41541562 | PubTator, text mining | PubMed |
| Human OAT1, OAT3, OAT4 and OATP1A2 Facilitate the Renal Accumulation of Ochratoxin A. | Pharmaceutics | 2025 | 41304811 | PubTator, text mining | PubMed |
| Molybdenum-bridged endo-exogenous antioxidant synergy reverses acute kidney injury via mitochondrial homeostasis reconstruction. | Bioact Mater | 2025 | 41268347 | PubTator, text mining | PubMed |
| Serine encodes drug selectivity in human OAT1. | Structure | 2025 | 41202796 | PubTator, text mining | PubMed |
| Modulation of NLRP3 inflammasome and uric acid metabolism by small molecule pectin from Premna ligustroides Hemsl leaves: Implications for hyperuricemia management. | Int J Biol Macromol | 2025 | 41075904 | PubTator, text mining | PubMed |
| Establishment and validation of a recurrent prediction model for glioma: extrinsic apoptotic molecules FADD and CASP8 are closely associated with glioma recurrence. | BMC Immunol | 2025 | 41013216 | PubTator, text mining | PubMed |
| Proteomic Analysis Infers Optimized ATP-Production in Guard Cell Mitochondria. | Physiol Plant | 2025 | 40999960 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9356/papers?page=2